Sanofi Genzyme hit with patent lawsuit over new eczema drug – Boston Business Journal

Posted: April 21, 2017 at 2:00 am


Boston Business Journal
Sanofi Genzyme hit with patent lawsuit over new eczema drug
Boston Business Journal
Immunex Corp., a subsidiary of Amgen (Nasdaq: AMGN), filed a complaint in Los Angeles federal court on April 5 claiming that an eczema drug developed by Sanofi (NYSE: SNY) and Regeneron Pharmaceuticals (Nasdaq: REGN) infringes a patent related to ...
Amgen, already on PCSK9 offense, slaps Sanofi, Regeneron with Dupixent patent suitFiercePharma

all 2 news articles »

Go here to see the original:
Sanofi Genzyme hit with patent lawsuit over new eczema drug - Boston Business Journal

Related Posts